Jonathan Elsner, Phd, Mba Email & Phone Number

Frederick, MD, US

Burlington, Massachusetts, US

• In my role as Vice President of Clinical Affairs, I established and managed the U.S. office, overseeing all operational activities. I
• directed clinical and marketing initiatives surrounding the company’s pivotal IDE multi-center trial for a device utilized in oncological robotic surgery.
• Recruited KOLs and activated 15 of the top U.S. hospitals within less than two years from IDE approval.
• Despite industry-wide challenges posed by COVID-19 and stringent eligibility criteria, I successfully recruited Key Opinion Leaders and activated 15 top U.S. hospitals within a year post-IDE approval.
• My strategic marketing initiatives resulted in a significant increase in patient enrollment, achieving a fourfold increase year-over-year.
• Led a diverse team, managed budgeting and contract negotiations, and maintained client relationships.

• Spearheaded a multinational clinical team overseeing the company’s pivotal IDE multi-center trial for the revolutionary cartilage regeneration device, GelrinC®, across 24 sites spanning the U.S., Europe, and Israel.
• I orchestrated day-to-day clinical operations, managing vendors including Contract Research Organizations (CROs), labs, and Electronic Data Capture (EDC) systems, ensuring impeccable subject retention and data.
• Through the implementation of an innovative marketing strategy, I achieved a remarkable threefold increase in patient enrollment year-over-year
• Led strategic communication with CMS, resulting in a crucial coverage decision for the GelrinC® clinical trial.
• Oversaw the development of essential study documents, including protocols, amendments, Investigator’s Brochures (IB), Data Management Plans (DMP), Statistical Analysis Plans (SAP), Informed Consent Forms (ICF), and.
• Guided the development of Standard Operating Procedures (SOPs), and ensured compliance with regulatory standards and quality controls, including oversight of Data Safety Monitoring Board (DSMB) committee meetings and.

Memphis, USCA, US

• Throughout my tenure, I pioneered groundbreaking advancements in healthcare technology, notably inventing the NUsurface® Meniscus Implant—a revolutionary solution addressing the primary cause of knee osteoarthritis and.
• At the helm of the NUsurface Implant's pivotal trials in the U.S., I orchestrated the technological sections of the PMA application, securing IDE and De-Novo FDA trial approvals. Steering IDE multi-center clinical.
• Implementing lean management practices, I optimized trial processes, ensuring predictable patient enrollment and surpassing targets with a 4x increase through innovative marketing strategies recognized by the PR.
• My leadership extended beyond clinical trials, encompassing comprehensive research and development projects in biomaterials, biomechanics, computational modeling, and animal studies, resulting in prolific scholarly.
• Guiding the transition from R&D to commercialization, I oversaw the launch of the NUsurface® System in the European market, directing programs for surgical instruments, user training, and accompanying materials..

Tel Aviv, IL

Master Of Business Administration (Mba), Entrepreneurship/Entrepreneurial Studies

Phd, Biomedical Engineering

B.Sc., Biomedical Engineering